文献速递儿童心血管与肾脏儿童感染

2017—2018年日本川崎病全国调查:流行病学、治疗与心脏并发症

Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.
PubMed 文献 · J Pediatr · 2020-05-23

2018年0—4岁儿童年发病率达359/10万,为最高;发病30天内9.0%出现心脏并发症,2.6%遗留心脏后遗症。结论认为日本川崎病年发病人数自1970年增至2018年,而近二十年心脏并发症比例下降。

要点

  • 2018年0—4岁儿童川崎病年发病率为359/10万,为调查中最高。
  • 初始IVIG治疗者中19.7%无应答。
  • 发病30天内9.0%出现心脏并发症,2.6%遗留心脏后遗症。

核心结论

  • 日本川崎病年发病人数从1970年持续增加至2018年,但近二十年心脏并发症比例下降。
  • 早期诊断与初始治疗进步可能解释上述变化。

研究设计与样本

  • 日本自1970年起每两年开展一次全国川崎病调查,最近一次于2019年完成。
  • 调查对象为2017—2018年发病的川崎病患者,问卷发至全国儿科专科医院及床位≥100张且设儿科病房的医院。

主要发现

  • 2018年0—4岁儿童年发病率最高,为359/10万。
  • 1982年后具备≤4项主要川崎病体征的患者逐渐增多,2017—2018年诊断6847例(21.1%)。
  • 发病30天内9.0%的患者诊断心脏并发症,2.6%在急性期后出现心脏后遗症。

关键数值与推荐

  • 2018年0—4岁儿童川崎病年发病率为359/10万。
  • 心脏并发症为发病30天内诊断,占9.0%;心脏后遗症为急性期后出现,占2.6%。

临床怎么用

  • 儿科医生应关注川崎病早期诊断,尤其是不完全川崎病比例上升的情况。
  • 对初始IVIG治疗需评估应答,约两成患者无应答。
  • 发病30天内应监测心脏并发症,并关注急性期后的心脏后遗症。

局限性

  • 调查对象为最终收治川崎病患者的医院,可能未覆盖未住院或未就诊患者。
  • 摘要未报告IVIG无应答的定义标准及心脏并发症的具体诊断方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the epidemiologic characteristics, treatments, and cardiac complications of Kawasaki disease, using data from the nationwide survey in Japan. STUDY DESIGN: The nationwide Kawasaki disease survey in Japan has been conducted biennially since 1970. The most recent survey was completed in 2019, obtaining information for patients who developed Kawasaki disease during 2017-2018. Survey respondents were hospitals specializing in pediatrics and those with ≥100 beds and a pediatric department throughout Japan, where patients with Kawasaki disease were eventually hospitalized. RESULTS: The survey identified 32 528 patients with Kawasaki disease, which consisted of 15 164 (46.6%) in 2017 and 17 364 (53.4%) in 2018. The highest annual incidence rate was recorded in 2018 (359 per 100 000 children aged 0-4 years). After 1982, patients with ≤4 principal Kawasaki disease signs gradually increased, resulting in 6847 (21.1%) patients diagnosed during 2017-2018. Among the 30 784 patients receiving initial intravenous immunoglobulin administration, 6061 (19.7%) did not respond. Within 30 days of Kawasaki disease onset, 9.0% of patients were diagnosed with cardiac complications, and 2.6% of patients developed cardiac sequelae after the acute illness. CONCLUSIONS: The annual number of patients developing Kawasaki disease in Japan increased from 1970 through 2018, whereas the proportion of patients with Kawasaki disease with cardiac complications decreased in the most recent 2 decades. Early diagnosis of Kawasaki disease as well as advances in initial treatments could explain these findings.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Ae R, Makino N, Kosami K, et al. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018. J Pediatr. 2020. PMID: 32454114. doi:10.1016/j.jpeds.2020.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。